Cavazzana is presenting data on the two patients at the annual meeting of the European Hematological Society in Milan, Italy.

We identified 95 phosphopeptides presented on the surface of primary hematological tumors and normal tissues, including 61 that were tumor-specific.

WAS expression was restored to near-physiological levels in the patients, resulting in immunological and hematological improvement and clinical benefit.